By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427



Company News
Amarantus BioSciences, Inc. Announces Issuance Of United States Patent No. 9,066,903 Covering Proprietary Methods Of Administration Of Eltoprazine For The Treatment Of Parkinson's Disease 6/30/2015 7:24:45 AM
Amarantus BioSciences, Inc. To Present At The BIO International Convention 6/10/2015 8:00:48 AM
Amarantus BioSciences, Inc. Completes Capital Restructuring In Preparation For National Exchange Listing 6/10/2015 7:27:02 AM
Amarantus BioSciences, Inc. Opens First Clinical Trial Site And Commences Patient Enrollment For Lead Product Candidate Eltoprazine's Phase IIb Study In Parkinson's Disease Levodopa-Induced Dyskinesia 6/5/2015 7:17:34 AM
Amarantus BioSciences, Inc. To Present At The Fourth Annual SeeThru Equity Microcap Investor Conference On May 28, 2015 5/26/2015 7:57:17 AM
Amarantus BioSciences, Inc. Effects Capital Restructuring In Anticipation Of National Exchange Listing 5/22/2015 6:11:49 AM
Amarantus BioSciences, Inc. Enters Into CRO Agreement With Chiltern International Ltd. To Commence Phase IIb Clinical Development Of Eltoprazine In Parkinson's Disease Levodopa-Induced Dyskinesia 5/21/2015 11:01:01 AM
Amarantus BioSciences, Inc. Reports First Quarter 2015 Financial Results And Business Overview 5/20/2015 11:49:12 AM
Amarantus BioSciences, Inc. To Present At Two Upcoming Investor Conferences 5/20/2015 8:24:33 AM
Amarantus BioSciences, Inc. Announces Successful Delivery And Distribution Of MANF In Preclinical Model To Brain Areas Involved In Parkinson's Disease 5/15/2015 7:07:14 AM